Dr. John Paul Shen joins the Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation’s Medical Advisory Board

Dr. Shen is an Assistant Professor in the Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center with a clinical practice focused on appendiceal and colon cancer. Dr. Shen is a physician-scientist with a scientific background in chemical biology and clinical training in Internal Medicine, Hematology, and Oncology.

Dr. Shen’s long-term research goal is to better understand the cancer genome and to leverage that understanding to better the delivery of chemotherapy. His immediate research goals include the discovery of new synthetic lethal genetic relationships as a means to both repurpose drugs already approved by the FDA to treat other conditions and to also identify new chemotherapeutic drug targets.

Dr. Shen is also actively involved in several projects to identify genomic biomarkers to predict what specific patients will respond to in a given therapy.

View our full Medical Advisory Board at https://acpmp.org/about-us/medical-advisory-board/